Medical Device News Magazine

Forum Health Launches Groundbreaking AI Technology to Detect Signs of Heart Disease at an Earlier Stage

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Forum Health Fond du Lac, a Forum Health national integrative and functional medicine network, has launched the Multifunction Cardiogram™ (MCG™) scan for early detection of heart disease and cardiac abnormalities.

Phil Hagerman, Forum Health CEO: “Our vision is to use advanced technologies like AI in everything we do. The MCG™ scan uses AI to identify potential heart issues before they escalate into life-threatening conditions. Fond du Lac is the first clinic in our network to launch this technology with great success and we plan to expand it to other clinics.”

The MCG™ scan is a preventative measure that can be used in youth and general populations that are increasingly at risk of heart-related disease. Unlike traditional methods that rely on the onset of symptoms, the MCG™ scan uses advanced artificial intelligence (AI) technology to identify a wide range of cardiac concerns, including:

-Coronary artery disease
-Myocarditis
-Microvascular disease
-Rhythm disturbances
-Heart stiffening
-Plaque instabilities
-Occlusions with high sensitivity

Dr. Steven Meress, Forum Health Fond du Lac: “The MCG™ scan is a revolutionary cardiac device. In March 2023, we performed the first round of scans; five months later, 12 out of 12 follow-up scans show improvement. This evidence shows how effective early interventions can be when based off the MCG™ scan and the positive impact on cardiac health.”

The Multifunction Cardiogram™ scan is powered by AI-driven technology, which continuously learns and improves with each test conducted. Each scan is compared to a robust database of more than 200,000 patients with established cardiovascular disease and assigned an objective heart dysfunctional burden score. This score ranks the patient’s heart health, empowering physicians to make informed decisions and develop personalized treatment plans.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”